Advertisement

Topics

A1M Pharma Company Profile

19:29 EST 4th December 2016 | BioPortfolio

A1M Pharma develops a diagnostic method and a novel treatment for the damaging effects of pre-eclampsia, a condition that affects around 10 million pregnant women worldwide. This disorder is responsible for 76,000 maternal and 500,000 infant deaths each year. It is also the cause of 15 per cent of all premature births. Currently, there is no predictive diagnostic method or treatment for impairments to kidney function associated with pre-eclampsia. In serious cases, doctors are forced to terminate the pregnancy which leads to premature infants and results in a substantial health care cost burden. Several preclinical studies indicate that A1M Pharma’s candidate drug, ROSGard™, based on the endogenous protein alpha-1-microglobulin, restores impairments to kidney function by repairing damaged tissue and protecting against oxidative stress. Kidney injury is a condition which is often associated with major surgery and with cancer treatments using radiation therapies. The company is therefore also developing a treatment for these acute kidney injuries. The first indication is kidney protection in connection with PRRT – a targeted radiation therapy for cancer – with the aim of opening the possibility of increasing treatment levels and so fight the cancer more effectively. Every year, over 12 million people are affected by acute kidney injuries that can lead to permanent kidney damage.

Location

Scheelevägen 22
Lund
223 63
Sweden

Contact

Phone: +46 46 286 50 30


News Articles [1353 Associated News Articles listed on BioPortfolio]

Fosun’s Yao Pharma invests big in global reach, by Wang Fangqing

As a major member of Fosun Pharma family, Chongqing-based Yao Pharma is a key part of Fosun Pharma’s…

VERONA PHARMA PLC - Notice of GM

Verona Pharma plc ("Verona Pharma" or the "Company") Confirmation of General Meeting Date 1 July 2016, Cardiff - Verona Pharma plc (AIM: VRP), the drug development company focused on first-in-clas...

Sun Pharma inks distribution pact with Japanese firm Mitsubishi pharma

Biospectrum Sun Pharma announces distribution alliance with Mitsubishi Tanabe Pharma Corporation in Japan [Read more]

Kiadis Pharma Appoints PCT as its Contract Manufacturing Organization in the United States

~ PCT will supply study medication for the US part of Kiadis Pharma's Phase III clinical trial with ATIR101™ ~ Regulatory News: Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amst.....

Sun Pharma gains license to SPARC's epilepsy drug

Sun Pharma and its subsidiary Sun Pharma Advanced Research Co.  -More- 

SPARC licenses Elepsia XR to Sun Pharma

Sun Pharma Advanced Research Company and India’s largest drugmaker Sun Pharma have entered into a licensing…

Big Pharma Sues Big Pharma in Biosimilar Cases

With the number of pharma lawsuits growing quickly, lawyers say the legal landscape has recently gotten a lot more complex

Tetra Bio-Pharma Inc. Announces that its Phase I Trial of Inhaled Marijuana in Healthy Volunteers Will Be Performed by Algorithme Pharma, an Altasciences Company

OTTAWA, ONTARIO -- (Marketwired) -- 09/29/16 -- Tetra Brio-Pharma Inc. ("Tetra" or the "Company") (CSE: TBP)(CSE: TBP.CN), through its wholly-owned subsidiary, PhytoPain Pharma Inc. ("PPP"), a pha...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [14 Associated PubMed Articles listed on BioPortfolio]

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

A Review of "Big Pharma, Women, and the Labour of Love"by Thea Cacchioni. Toronto, Canada: University of Toronto Press, 2015, 167 pages, $50.00 (hardcover), $21.95 (paperback), $20.85 (Kindle).

Cognitive disorders in stroke patients: the possibilities of pharma-cological correction.

To determine the efficacy and safety of cellex in treatment of cognitive disorders in acute ischemic stroke (IS).

Assessment of the Combined Efficacy of Needling and the Use of Silicone Gel in the Treatment of C-Section and Other Surgical Hypertrophic Scars and Keloids.

To evaluate the individual effectiveness of needling therapy using the Dermapen (Dermapen, Salt Lake City, Utah) and topical therapy with silicone gel (Kelo-cote, Sinclair Pharma, London, England), an...

A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.

U.S. Food and Drug Administration-approved formulations of botulinum toxin include onabotulinumtoxinA (Botox; Allergan, Inc., Irvine, Calif.), abobotulinumtoxinA (Dysport; Galderma Pharma S.A., Lausan...

Clinical Trials [67 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [693 Associated Companies listed on BioPortfolio]

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

Flex Pharma, Inc.

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human effi...

More Information about "A1M Pharma" on BioPortfolio

We have published hundreds of A1M Pharma news stories on BioPortfolio along with dozens of A1M Pharma Clinical Trials and PubMed Articles about A1M Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A1M Pharma Companies in our database. You can also find out about relevant A1M Pharma Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...


Corporate Database Quicklinks



Searches Linking to this Company Record